Analystreport

Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Quoin Pharmaceuticals, Ltd. - American Depositary Shares  (QNRX)